Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research shows aspirin therapy didn’t work in almost half of stroke patients studied

21.07.2004


Northwestern Memorial research shows an aspirin a day may not keep strokes away

Northwestern Memorial researchers have found that nearly half of patients who suffered a stroke or transient ischemic attack (TIA) after having been committed to aspirin therapy were "aspirin resistant," meaning the aspirin wasn’t producing the antiplatelet (blood-thinning) effect needed to avoid these health threats. Aspirin resistance increased when patients had been taking baby (81 mg) or enteric coated aspirin.

"Previous studies conducted at Northwestern Memorial Hospital showed the majority of patients taking low-dose or coated aspirin are not getting the desired antiplatelet effect," explains Mark J. Alberts, M.D., director of the stroke program at Northwestern Memorial Hospital. "Now, we’ve taken our research one step further and shown that aspirin resistance does, in fact, correlate with clinical events. Many patients who are committed to taking aspirin each day are still having strokes or transient ischemic attacks." Dr. Alberts recently presented these findings at the 5th World Stroke Congress in Vancouver, Canada.



"This study is significant because it gets researchers one step closer to determining how we can maximize the effectiveness of aspirin," adds Dr. Alberts. "The long-term goal of this line of research is to determine if we can better tailor the type and strength of aspirin to maximize its effects as an anti-clotting agent, which may require routine testing of antiplatelet effects for individual patients.

"The message for patients is clear: do not rely on taking aspirin alone for reducing the risk of stroke. There are tried and true methods that have been shown to reduce the risk of stroke, which include controlling your blood pressure and diabetes, stopping smoking, eating right and exercising."

Northwestern Memorial investigators collected data on 59 patients who came to the hospital with a stroke or TIA. They studied the chronic aspirin users, requiring that patients had been taking aspirin for at least three days prior to admission. Antiplatelet effects of aspirin were measured at the time of admission using a machine about the size of a coffee maker — called a PFA 100 — which can quickly, easily and reliably measures platelet function in response to aspirin.

  • 22 patients were taking a baby aspirin; 73% of this patient group had no antiplatelet effect
  • 37 patients were taking an adult aspirin; 32% of this patient group had no antiplatelet effect

Information about aspirin formulation was only available for 29 patients.

  • 18 patients were taking coated aspirin; 73% had no antiplatelet effect
  • 11 patients were taking uncoated aspirin; 39% had no antiplatelet effect

This study indicates that adult aspirin produces more blood-thinning results than baby and/or enteric coated aspirin. Results from a prior study suggested that older women were more likely to experience aspirin resistance.

A stroke or "brain attack" occurs when blood circulation to the brain becomes interrupted. The most common type of stroke, ischemic stroke, occurs when an artery narrows or a blood clot blocks blood flow in an artery supplying the brain. A clot can form because of sluggish blood flow through a vessel narrowed by fatty deposits. The goal of aspirin is to thin the blood, thereby reducing the risk of blood clots.

Stroke is the third leading cause of death in the United States. Each year, approximately 750,000 patients have a stroke and 165,000 of them die. Increasing age is a major risk factor for stroke, so as the population ages, strokes become even more common.

Co-authors include: Deborah Bergman, NP, Mary Soeding, RN, Richard Bernstein, M.D., Glenn Ramsey, M.D., and Paul Lindholm, M.D.

Patty Keiler | EurekAlert!
Further information:
http://www.nmh.org

More articles from Studies and Analyses:

nachricht Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung

nachricht Scientists reveal source of human heartbeat in 3-D
07.08.2017 | University of Manchester

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>